Biotech · Public company · South San Francisco, CA, US
Maze Therapeutics, Inc.
Ticker MAZE · SEC CIK 0001842295
Track this companyFree. Adds Maze Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- MZE782Phase 2 · Phenylketonuria (PKU)ClinicalTrials.gov · fetched Nov 12, 2026
- MZE829Phase 2 · Proteinuric Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MZE001Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of MZE782 in Adults With PKUPHASE2 · RECRUITING · started Jun 23, 2026ClinicalTrials.gov NCT07694440 · fetched Nov 12, 2026
- A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseasePHASE2 · RECRUITING · started Feb 5, 2025ClinicalTrials.gov NCT06830629 · fetched Nov 12, 2026
- A Randomized Phase 1 of of MZE001 in Healthy VolunteersPHASE1 · COMPLETED · started Feb 7, 2022ClinicalTrials.gov NCT05249621 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 17, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 25, 2026 · fetched Nov 12, 2026